bioAffinity Technologies Gross Margin Growth & History (BIAF)

bioAffinity Technologies's gross margin was 30.53% for fiscal 2025.

View full bioAffinity Technologies company overview

bioAffinity Technologies annual gross margin history

bioAffinity Technologies annual gross margin

Fiscal yearPeriod endedGross marginChange (percentage points)
20252025-12-3130.53%−5.56 pp
20242024-12-3136.09%+4.83 pp
20232023-12-3131.26%−59.02 pp
20222022-12-3190.28%

bioAffinity Technologies gross margin trends

Between the periods ended 2022-12-31 and 2025-12-31, bioAffinity Technologies's gross margin decreased from 90.28% to 30.53%, a change of −59.75 percentage points. The latest reported quarter, Q2 2026, shows 27.99%.

About the metric

What gross margin means

Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.

Calculation and source

How gross margin is calculated

TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review bioAffinity Technologies source filings ↗

Community posts

It’s quiet here.

No posts about BIAF yet. Start the conversation.

Write the first post